Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canntab Therapeutics Ltd C.PILL

Alternate Symbol(s):  CTABF

Canntab Therapeutics Limited is a Canadian phytopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The Company’s operations comprise a single segment engaged in the medical marijuana business. The Company’s hard pill cannabinoid formulations provide doctors, patients, and consumers with medical grade solutions. These include once a day and extended-release formulations. Its products include INSTANT RELEASE - (IR Tablet), EXTENDED-RELEASE - (XR Tablet), and ORAL DISSOLVING - O.D. Tablet (ODT). The IR Tablet is a release profile for solid hard tablets. The XR Tablet is a phytocannabinoid vehicle that is designed to directly address the drawbacks and challenges of competing oral delivery systems. ODT is specifically designed to dissolve directly in the patient’s mouth, with an onset of action between five and thirty minutes.


CSE:PILL - Post by User

Comment by canaken1on Jun 21, 2018 1:04pm
90 Views
Post# 28206723

RE:RE:RE:Emblem News

RE:RE:RE:Emblem NewsTony:- Looking at the brief summary of the October 3, 2017 License Agreement between Canntab & Emblem(EMC), EMC will have the exclusive rights for the sale of the XR tablets in Canada . Where it gets murky for me is,  I do not see any statements that EMC is not allowed to sell the manufactured products internationnaly. Royalty payments on the products sold is stated as being "In the territory " on sale.. not in Canada.
Based on what I've read, I'm of the opinion that EMC can sell whatever products they manufacture to Acnos Phama and Canntab will collect royalties for the products covered by the license agreement. Will appreciate if you can link me to where you see that EMC can only manufacture & sell the licensed products in Canada.tia







I don't see any statement saying they are not allowed to sell the XR products internationally.
<< Previous
Bullboard Posts
Next >>